MONOLISA Anti HBc Plus - Serbia Registration d099de7e4c4bdedb75bb71ef51ebb576
Access comprehensive regulatory information for MONOLISA Anti HBc Plus in Serbia's medical device market through Pure Global AI's free database. This medical device is registered under number d099de7e4c4bdedb75bb71ef51ebb576 and manufactured by BIO-RAD. The local agent in Serbia is BROKER DOO BEOGRAD with registration valid from Sep 19, 2023 to Jun 02, 2027.
This page provides complete technical specifications for this device, regulatory compliance details. Pure Global AI offers free access to 234+ Serbian medical device registrations, helping global MedTech companies navigate Serbia ALIMS regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
d099de7e4c4bdedb75bb71ef51ebb576
515-02-02861-23-003
D
in places designated by the ministry responsible for health affairs on the operation of wholesale and retail sale of medical devices, based on regulations in the field of medical devices and health care.
Registration Period
Sep 19, 2023
Jun 02, 2027
Sep 25, 2023

